Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: SGE1

While we considered the comments regarding the filing of a Form 8-K announcing a change in filing deadline status, and while we considered whether to require disclosure in a company’s Form 10-Q for its second fiscal quarter to provide investors with advance notice that a company would be exiting accelerated filer or large accelerated filer status, we have decided that a mandated disclosure requirement is not justified, given the infrequency of such an occurrence.

.

.

.

Be well

Share
New Message
Please login to post a reply